drugset / Trial / NCT02777723

Study to Evaluate the Efficacy and Safety of CKD-350

NCT02777723

Phase 3 Unknown 138 enrolled Chong Kun Dang Pharmaceutical
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to compare the efficacy and safety of CKD-350 in patients with dry eye syndrome

Timeline

Start
2016-05
Primary completion
2016-07
Completion
2016-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sodium Hyaluronate Other / unclassified 0.3 %
Subject Xenobella Unknown 0.3 %

Indications